Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
C

CLOV

Nasdaq

CLOVER HEALTH INVESTMENTS, CORP. /DE

Latest disclosureOctober 7, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 29 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 49

Limited filing history
All49Buying0Selling29Other20
Filters

Last 30 daysNo qualifying insider buying. Sales: $3M by 5 insiders.

20 of 49 trades · April 1, 2026 – October 7, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Award disclosed

Brian James Miller

Director

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 30, 2026Filed October 2, 2026SEC filing
Award disclosed

Robert G. Torricelli

Director

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 30, 2026Filed October 2, 2026SEC filing
Award disclosed

Karen Soares

Chief Legal Officer

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 12, 2026Filed August 13, 2026SEC filing
Award disclosed

Joseph Clay Thornton

Interim CFO

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 12, 2026Filed August 13, 2026SEC filing
Tax or exercise withholding

Joseph Clay Thornton

Interim CFO

Class A Common Stock

Value context
$58.79K
Reported price
$3.47 / share
Traded May 16, 2026Filed May 18, 2026SEC filing
Tax or exercise withholding

Andrew Toy

Chief Executive Officer

Class A Common Stock

Value context
$241.69K
Reported price
$2.82 / share
Traded May 8, 2026Filed May 12, 2026SEC filing
Tax or exercise withholding

Brady Patrick Priest

CEO of Clover Care Services

Class A Common Stock

Value context
$79.09K
Reported price
$2.19 / share
Traded April 18, 2026Filed April 21, 2026SEC filing
Tax or exercise withholding

Brady Patrick Priest

CEO of Clover Care Services

Class A Common Stock

Value context
$31.56K
Reported price
$2.04 / share
Traded April 15, 2026Filed April 16, 2026SEC filing
Tax or exercise withholding

Karen Soares

Chief Legal Officer

Class A Common Stock

Value context
$20.73K
Reported price
$2.04 / share
Traded April 15, 2026Filed April 16, 2026SEC filing
Tax or exercise withholding

Andrew Toy

Chief Executive Officer

Class A Common Stock

Value context
$123.96K
Reported price
$2.04 / share
Traded April 15, 2026Filed April 16, 2026SEC filing
Tax or exercise withholding

Joseph Clay Thornton

Interim CFO

Class A Common Stock

Value context
$8.48K
Reported price
$2.04 / share
Traded April 15, 2026Filed April 16, 2026SEC filing
Tax or exercise withholding

Jamie L. Reynoso

CEO, Medicare Advantage

Class A Common Stock

Value context
$25.93K
Reported price
$2.04 / share
Traded April 15, 2026Filed April 16, 2026SEC filing
Tax or exercise withholding

Conrad Wai

CEO, Counterpart Health

Class A Common Stock

Value context
$47.86K
Reported price
$2.04 / share
Traded April 15, 2026Filed April 16, 2026SEC filing
Tax or exercise withholding

Jamie L. Reynoso

CEO, Medicare Advantage

Class A Common Stock

Value context
$10.66K
Reported price
$1.72 / share
Traded April 3, 2026Filed April 7, 2026SEC filing
Award disclosed

Brady Patrick Priest

CEO of Clover Care Services

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 1, 2026Filed April 3, 2026SEC filing
Award disclosed

Jamie L. Reynoso

CEO, Medicare Advantage

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 1, 2026Filed April 3, 2026SEC filing
Award disclosed

Andrew Toy

Chief Executive Officer

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 1, 2026Filed April 3, 2026SEC filing
Tax or exercise withholding

Andrew Toy

Chief Executive Officer

Class A Common Stock

Value context
$544.82K
Reported price
$1.76 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Award disclosed

Conrad Wai

CEO, Counterpart Health

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 1, 2026Filed April 3, 2026SEC filing
Award disclosed

Karen Soares

Chief Legal Officer

Class A Common Stock

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 1, 2026Filed April 3, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorClass A Common StockGrant or award12,481Award · no purchase priceNon-cash awardSep 30Filed Oct 2 · 2d laterSEC filing
DirectorClass A Common StockGrant or award12,481Award · no purchase priceNon-cash awardSep 30Filed Oct 2 · 2d laterSEC filing
Chief Legal OfficerClass A Common StockGrant or award108,695Award · no purchase priceNon-cash awardAug 12Filed Aug 13 · 1d laterSEC filing
Interim CFOClass A Common StockGrant or award54,347Award · no purchase priceNon-cash awardAug 12Filed Aug 13 · 1d laterSEC filing
Interim CFOClass A Common StockExercise-price or tax withholding16,942$3.47 / share$58.79KMay 16Filed May 18 · 2d laterSEC filing
Chief Executive OfficerClass A Common StockExercise-price or tax withholding85,704$2.82 / share$241.69KMay 8Filed May 12 · 4d laterSEC filing
CEO of Clover Care ServicesClass A Common StockExercise-price or tax withholding36,113$2.19 / share$79.09KApr 18Filed Apr 21 · 3d laterSEC filing
CEO of Clover Care ServicesClass A Common StockExercise-price or tax withholding15,471$2.04 / share$31.56KApr 15Filed Apr 16 · 1d laterSEC filing
Chief Legal OfficerClass A Common StockExercise-price or tax withholding10,161$2.04 / share$20.73KApr 15Filed Apr 16 · 1d laterSEC filing
Chief Executive OfficerClass A Common StockExercise-price or tax withholding60,765$2.04 / share$123.96KApr 15Filed Apr 16 · 1d laterSEC filing
Interim CFOClass A Common StockExercise-price or tax withholding4,158$2.04 / share$8.48KApr 15Filed Apr 16 · 1d laterSEC filing
CEO, Medicare AdvantageClass A Common StockExercise-price or tax withholding12,712$2.04 / share$25.93KApr 15Filed Apr 16 · 1d laterSEC filing
CEO, Counterpart HealthClass A Common StockExercise-price or tax withholding23,463$2.04 / share$47.86KApr 15Filed Apr 16 · 1d laterSEC filing
CEO, Medicare AdvantageClass A Common StockExercise-price or tax withholding6,197$1.72 / share$10.66KApr 3Filed Apr 7 · 4d laterSEC filing
CEO of Clover Care ServicesClass A Common StockGrant or award191,261Award · no purchase priceNon-cash awardApr 1Filed Apr 3 · 2d laterSEC filing
CEO, Medicare AdvantageClass A Common StockGrant or award159,384Award · no purchase priceNon-cash awardApr 1Filed Apr 3 · 2d laterSEC filing
Chief Executive OfficerClass A Common StockGrant or award956,307Award · no purchase priceNon-cash awardApr 1Filed Apr 3 · 2d laterSEC filing
Chief Executive OfficerClass A Common StockExercise-price or tax withholding309,558$1.76 / share$544.82KApr 1Filed Apr 3 · 2d laterSEC filing
CEO, Counterpart HealthClass A Common StockGrant or award267,766Award · no purchase priceNon-cash awardApr 1Filed Apr 3 · 2d laterSEC filing
Chief Legal OfficerClass A Common StockGrant or award382,522Award · no purchase priceNon-cash awardApr 1Filed Apr 3 · 2d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for CLOV in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001801170
Latest public acceptance
Oct 7, 2026, 10:20 PM UTC
Score calculated
Oct 7, 2026, 10:22 PM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.